Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Cervical Cancer

  Free Subscription


29.08.2022

1 Am J Prev Med
2 Biomolecules
1 BJOG
1 BMC Public Health
3 BMC Womens Health
1 Br J Biomed Sci
1 Br J Cancer
1 Br J Radiol
3 Cancers (Basel)
1 Cell Mol Biol (Noisy-le-grand)
1 Cells
1 Chem Biodivers
1 Cochrane Database Syst Rev
1 Contrast Media Mol Imaging
1 Curr Cancer Drug Targets
1 Curr Comput Aided Drug Des
2 Curr Oncol
2 Diagnostics (Basel)
1 Discov Oncol
1 Endocrinol Diabetes Metab Case Rep
1 Environ Sci Pollut Res Int
1 Epidemiol Health
1 Epidemiol Infect
1 ESMO Open
1 Eur Rev Med Pharmacol Sci
1 Expert Rev Med Devices
1 Front Cell Infect Microbiol
1 Front Genet
1 Front Oncol
1 Gene
2 Genes (Basel)
1 Infect Dis Obstet Gynecol
1 Int J Gynecol Cancer
1 Int Urogynecol J
1 J Cancer Educ
1 J Cancer Policy
1 J Clin Med
1 J Comput Assist Tomogr
1 J Educ Health Promot
1 J Low Genit Tract Dis
1 J Transl Med
1 J Virol
1 Lancet Reg Health West Pac
1 Magn Reson Imaging
1 Neoplasma
1 Nucl Med Commun
1 Oncogene
1 Pak J Med Sci
1 Pak J Pharm Sci
1 Pathol Oncol Res
1 Prev Med
1 Psychooncology
1 Reprod Sci
1 Rev Panam Salud Publica
1 Scand J Public Health
1 Scanning
2 Sci Rep
1 Sovrem Tekhnologii Med
1 Vaccines (Basel)
1 Virusdisease
1 Viruses
1 World J Surg Oncol
1 Zhonghua Fu Chan Ke Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Prev Med

  1. SABATINO SA, Thompson TD, White MC, Shapiro JA, et al
    Cancer Screening Test Use-U.S., 2019.
    Am J Prev Med. 2022;63:431-439.
    PubMed         Abstract available


    Biomolecules

  2. GOMEZ-HERRANZ M, Faktor J, Yebenes Mayordomo M, Pilch M, et al
    Emergent Role of IFITM1/3 towards Splicing Factor (SRSF1) and Antigen-Presenting Molecule (HLA-B) in Cervical Cancer.
    Biomolecules. 2022;12.
    PubMed         Abstract available

  3. ZHANG Q, Zhu H, Cui Z, Li Y, et al
    The HPV16E7 Affibody as a Novel Potential Therapeutic Agent for Treating Cervical Cancer Is Likely Internalized through Dynamin and Caveolin-1 Dependent Endocytosis.
    Biomolecules. 2022;12.
    PubMed         Abstract available


    BJOG

  4. WIERSMA D, Vinke A, Siebers AG, Melchers WJG, et al
    The added value of digital imaging to reflex cytology for triage of high-risk human papillomavirus positive self-sampled material in cervical cancer screening: A prospective cohort study.
    BJOG. 2022 Aug 3. doi: 10.1111/1471-0528.17272.
    PubMed         Abstract available


    BMC Public Health

  5. EGBON M, Ojo T, Aliyu A, Bagudu ZS, et al
    Challenges and lessons from a school-based human papillomavirus (HPV) vaccination program for adolescent girls in a rural Nigerian community.
    BMC Public Health. 2022;22:1611.
    PubMed         Abstract available


    BMC Womens Health

  6. POWER R, Ussher JM, Hawkey A, Missiakos O, et al
    Co-designed, culturally tailored cervical screening education with migrant and refugee women in Australia: a feasibility study.
    BMC Womens Health. 2022;22:353.
    PubMed         Abstract available

  7. RAPITI E, Fournier E, Schaffar R
    High burden of invasive and non-invasive cancer among women aged 20-49 years: the situation in Geneva, Switzerland.
    BMC Womens Health. 2022;22:349.
    PubMed         Abstract available

  8. ELSHAMI M, Abukmail H, Al-Slaibi I, Alser M, et al
    Awareness of human papillomavirus and acceptability of the vaccine among women in Palestine: is it time for policy adjustment?
    BMC Womens Health. 2022;22:352.
    PubMed         Abstract available


    Br J Biomed Sci

  9. ABBAS M, Kushwaha VS, Srivastava K, Banerjee M, et al
    Understanding Role of DNA Repair and Cytochrome p-450 Gene Polymorphisms in Cervical Cancer Patient Treated With Concomitant Chemoradiation.
    Br J Biomed Sci. 2022;79:10120.
    PubMed         Abstract available


    Br J Cancer

  10. AASBO G, Trope A, Nygard M, Christiansen IK, et al
    HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial.
    Br J Cancer. 2022 Aug 23. pii: 10.1038/s41416-022-01954.
    PubMed         Abstract available


    Br J Radiol

  11. BENSON R, Rodgers J, Nelder C, Clough A, et al
    The impact of an educational tool in cervix image registration across three imaging modalities.
    Br J Radiol. 2022 May 26:20211402. doi: 10.1259/bjr.20211402.
    PubMed         Abstract available


    Cancers (Basel)

  12. LEFFERS M, Herbst J, Kropidlowski J, Prieske K, et al
    Combined Liquid Biopsy Methylation Analysis of CADM1 and MAL in Cervical Cancer Patients.
    Cancers (Basel). 2022;14.
    PubMed         Abstract available

  13. CHAN WL, Cheng MH, Wu JT, Choi CW, et al
    Treatment Outcomes of Computer Tomography-Guided Brachytherapy in Cervical Cancer in Hong Kong: A Retrospective Review.
    Cancers (Basel). 2022;14.
    PubMed         Abstract available

  14. CHANG CS, Min JS, Song KH, Choi CH, et al
    The Role of Conization before Radical Hysterectomy in Cervical Cancer including High Risk Factors of Recurrence: Propensity Score Matching.
    Cancers (Basel). 2022;14.
    PubMed         Abstract available


    Cell Mol Biol (Noisy-le-grand)

  15. LIANG M, Liu S, Huang W, Jiang L, et al
    Analysis of Mechanism of Action of Cuprous Oxide Nanoparticles in Treatment of Cervical Cancer under Real-time Ultrasound Elastography.
    Cell Mol Biol (Noisy-le-grand). 2022;68:402-410.
    PubMed         Abstract available


    Cells

  16. GARCIA-QUIROZ J, Vazquez-Almazan B, Garcia-Becerra R, Diaz L, et al
    The Interaction of Human Papillomavirus Infection and Prostaglandin E2 Signaling in Carcinogenesis: A Focus on Cervical Cancer Therapeutics.
    Cells. 2022;11.
    PubMed         Abstract available


    Chem Biodivers

  17. SI C, Ou Y, Ma D, Hei L, et al
    Cytotoxic Effect of the Essential oils from Erigeron Canadensis L. on Human Cervical Cancer HeLa Cells in Vitro.
    Chem Biodivers. 2022 Aug 25:e202200436. doi: 10.1002/cbdv.202200436.
    PubMed         Abstract available


    Cochrane Database Syst Rev

  18. KOKKA F, Bryant A, Olaitan A, Brockbank E, et al
    Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
    Cochrane Database Syst Rev. 2022;8:CD010260.
    PubMed         Abstract available


    Contrast Media Mol Imaging

  19. PENG Z, Liu K, Zhang Y, Hong Q, et al
    The 22-Item Benefit Finding Scale: Validation and Application among Patients with Cervical Cancer in Ethnic Minority Areas of Southwestern China.
    Contrast Media Mol Imaging. 2022;2022:8977011.
    PubMed         Abstract available


    Curr Cancer Drug Targets

  20. CHEN H, Feng R, Wang X, Cao C, et al
    Knockdown of PRKD2 Enhances Chemotherapy Sensitivity in Cervical Cancer via the TP53/CDKN1A Pathway.
    Curr Cancer Drug Targets. 2022 Aug 22. pii: CCDT-EPUB-125779.
    PubMed         Abstract available


    Curr Comput Aided Drug Des

  21. SUN H, Wang D, Xu M, Gao Y, et al
    Methodological Verification-Based Screening of the Representative Ingredients for Traditional Chinese Medicine: Taking Astragalus as An Example for Interfering with Cervical Cancer.
    Curr Comput Aided Drug Des. 2022 Aug 23. pii: CAD-EPUB-125801.
    PubMed         Abstract available


    Curr Oncol

  22. KRAUT R, Manca D, Lofters A, Babenko O, et al
    A Case for Offering HPV Self-Sampling to Well-Screened Women. Comment on Lesack et al. Willingness to Self-Collect a Sample for HPV-Based Cervical Cancer Screening in a Well-Screened Cohort: HPV FOCAL Survey Results. Curr. Oncol. 2022, 29, 3860-3869.
    Curr Oncol. 2022;29:5368-5369.
    PubMed         Abstract available

  23. BERNARDINI F, Ferrandina G, Ricci C, Fagotti A, et al
    Neoadjuvant Chemotherapy in Pregnant Patients with Cervical Cancer: A Monocentric Retrospective Study.
    Curr Oncol. 2022;29:5702-5714.
    PubMed         Abstract available


    Diagnostics (Basel)

  24. CHABEREK K, Mrowiec M, Kaczmarek M, Dutsch-Wicherek M, et al
    The Creation of the Suppressive Cancer Microenvironment in Patients with HPV-Positive Cervical Cancer.
    Diagnostics (Basel). 2022;12.
    PubMed         Abstract available

  25. MADEDDU C, Sanna E, Nemolato S, Mulas O, et al
    Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Report.
    Diagnostics (Basel). 2022;12.
    PubMed         Abstract available


    Discov Oncol

  26. REZA MS, Hossen MA, Harun-Or-Roshid M, Siddika MA, et al
    Metadata analysis to explore hub of the hub-genes highlighting their functions, pathways and regulators for cervical cancer diagnosis and therapies.
    Discov Oncol. 2022;13:79.
    PubMed         Abstract available


    Endocrinol Diabetes Metab Case Rep

  27. SAWAMURA T, Karashima S, Ohmori A, Sawada K, et al
    Hiccups as the first presentation of secondary adrenal insufficiency associated with advanced cervical cancer.
    Endocrinol Diabetes Metab Case Rep. 2022;2022.
    PubMed         Abstract available


    Environ Sci Pollut Res Int

  28. LI C, Li X, Zhang Y, Wu L, et al
    DSCAM-AS1 promotes cervical carcinoma cell proliferation and invasion via sponging miR-338-3p.
    Environ Sci Pollut Res Int. 2022;29:58906-58914.
    PubMed         Abstract available


    Epidemiol Health

  29. BOLORMAA E, Choe SA, Son M, Ki M, et al
    Income-based disparity in the risk distant-stage cervical cancer and mortality after introduction of a national cancer screening program.
    Epidemiol Health. 2022 Aug 11:e2022066. doi: 10.4178/epih.e2022066.
    PubMed         Abstract available


    Epidemiol Infect

  30. RATNASAMY P, Chagpar AB
    HPV vaccination and factors influencing vaccine uptake among people of Indian ancestry living in the United States.
    Epidemiol Infect. 2022;150:e152.
    PubMed         Abstract available


    ESMO Open

  31. YANG X, Ren H, Li Z, Zhang L, et al
    A phase III randomized, controlled trial of nedaplatin versus cisplatin concurrent chemoradiotherapy in patients with cervical cancer.
    ESMO Open. 2022;7:100565.
    PubMed         Abstract available


    Eur Rev Med Pharmacol Sci

  32. MOSCATO GMF, Galanti F, Criscuolo AA, Ciotti M, et al
    A retrospective study on two cohorts of immunocompetent women treated with nonavalent HPV vaccine vs. Ellagic acid complex: outcome of the evolution of persistent cervical HPV infection.
    Eur Rev Med Pharmacol Sci. 2022;26:5509-5519.
    PubMed         Abstract available


    Expert Rev Med Devices

  33. CORONADO MARTIN PJ, Gonzalez Gonzalez V, Fasero Laiz M
    Value of colposcopy with dynamic spectral imaging in the detection and evolution of high-grade cervical lesions.
    Expert Rev Med Devices. 2022;19:525-532.
    PubMed         Abstract available


    Front Cell Infect Microbiol

  34. GUO C, Dai W, Zhou Q, Gui L, et al
    Cervicovaginal microbiota significantly changed for HPV-positive women with high-grade squamous intraepithelial lesion.
    Front Cell Infect Microbiol. 2022;12:973875.
    PubMed         Abstract available


    Front Genet

  35. CHEN H, Chen X, Zeng F, Fu A, et al
    Prognostic value of SOX9 in cervical cancer: Bioinformatics and experimental approaches.
    Front Genet. 2022;13:939328.
    PubMed         Abstract available


    Front Oncol

  36. PENG QH, Chen K, Li JY, Chen L, et al
    Analysis of Treatment Outcomes and Prognosis After Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer.
    Front Oncol. 2022;12:926840.
    PubMed         Abstract available


    Gene

  37. SUN W, Hang D, Han S, Fu S, et al
    Construction of circRNA-associated ceRNA network reveals the regulation of fibroblast proliferation in cervical cancer.
    Gene. 2022 Aug 19:146824. doi: 10.1016/j.gene.2022.146824.
    PubMed         Abstract available


    Genes (Basel)

  38. BEKAMPYTE J, Savukaityte A, Bartnykaite A, Ugenskiene R, et al
    TIRAP Rs8177376, Rs611953, Rs3802814, and Rs8177374 Polymorphisms and Their Association with Cervical Cancer Phenotype and Prognosis.
    Genes (Basel). 2022;13.
    PubMed         Abstract available

  39. LE TM, Nguyen HDT, Lee E, Lee D, et al
    Transcriptomic Immune Profiles Can Represent the Tumor Immune Microenvironment Related to the Tumor Budding Histology in Uterine Cervical Cancer.
    Genes (Basel). 2022;13.
    PubMed         Abstract available


    Infect Dis Obstet Gynecol

  40. NAIDOO K, Abbai N, Tinarwo P, Sebitloane M, et al
    BV associated bacteria specifically BVAB 1 and BVAB 3 as biomarkers for HPV risk and progression of cervical neoplasia.
    Infect Dis Obstet Gynecol. 2022;2022:9562937.
    PubMed         Abstract available


    Int J Gynecol Cancer

  41. GLICKMAN A, Diaz-Feijoo B, Agusti N, Carreras-Dieguez N, et al
    Laparoscopically assisted radical vaginal hysterectomy in early-stage cervical cancer.
    Int J Gynecol Cancer. 2022 Aug 22. pii: ijgc-2022-003670.
    PubMed        


    Int Urogynecol J

  42. SHAN X, Qian M, Wang L, Liu X, et al
    Prevalence of pelvic floor dysfunction and sexual dysfunction in cervical cancer survivors: a systematic review and meta-analysis.
    Int Urogynecol J. 2022 Aug 24. pii: 10.1007/s00192-022-05326.
    PubMed         Abstract available


    J Cancer Educ

  43. HECHT ML, BeLue R, Ray A, Hopfer S, et al
    HPV Vaccine Intent among Adult Women Receiving Care at Community Health Centers.
    J Cancer Educ. 2022;37:1186-1193.
    PubMed         Abstract available


    J Cancer Policy

  44. KHUMALO PG, Carey M, Mackenzie L, Ampofo AG, et al
    Trends in cervical cancer screening research in sub-Saharan Africa: A bibliometric analysis of publications from 2001 to 2020.
    J Cancer Policy. 2022;34:100356.
    PubMed         Abstract available


    J Clin Med

  45. GASIMLI K, Wilhelm L, Becker S, De Wilde RL, et al
    New Insights on the Minimal-Invasive Therapy of Cervical Cancer.
    J Clin Med. 2022;11.
    PubMed         Abstract available


    J Comput Assist Tomogr

  46. GHANI MA, Liau J, Eskander R, Mell L, et al
    Imaging Biomarkers and Liquid Biopsy in Assessment of Cervical Cancer.
    J Comput Assist Tomogr. 2022 Aug 23. pii: 00004728-990000000-00066.
    PubMed         Abstract available


    J Educ Health Promot

  47. MALEKZADEH E, Nourizadeh R, Farshbaf-Khalili A, Mehrabi E, et al
    The effect of decision-aid-based counseling on cervical cancer screening behavior among women: An interventional study.
    J Educ Health Promot. 2022;11:205.
    PubMed         Abstract available


    J Low Genit Tract Dis

  48. GERTRUDES LN, Yoneda JY, Mirandez CC, Carvalho CF, et al
    Endocervical Margins Status in Excision for Preventing Cervical Cancer According to the Transformation Zone Type.
    J Low Genit Tract Dis. 2022 Aug 26. pii: 00128360-990000000-00015.
    PubMed         Abstract available


    J Transl Med

  49. ZHANG J, Li X, Yang J, Zhang Y, et al
    MiR-1254 suppresses the proliferation and invasion of cervical cancer cells by modulating CD36.
    J Transl Med. 2022;19.
    PubMed         Abstract available


    J Virol

  50. VATS A, Trejo-Cerro O, Massimi P, Banks L, et al
    Regulation of HPV E7 Stability by E6-Associated Protein (E6AP).
    J Virol. 2022 Aug 2:e0066322. doi: 10.1128/jvi.00663.
    PubMed         Abstract available


    Lancet Reg Health West Pac

  51. BREWER N, Foliaki S, Gray M, Potter JD, et al
    Pasifika women's knowledge and perceptions of cervical-cancer screening and the implementation of self-testing in Aotearoa New Zealand: A qualitative study.
    Lancet Reg Health West Pac. 2022;28:100551.
    PubMed         Abstract available


    Magn Reson Imaging

  52. ZHANG A, Hu Q, Song J, Dai Y, et al
    Value of non-Gaussian diffusion imaging with a fractional order calculus model combined with conventional MRI for differentiating histological types of cervical cancer.
    Magn Reson Imaging. 2022 Aug 18. pii: S0730-725X(22)00148.
    PubMed         Abstract available


    Neoplasma

  53. LI N, Ji GX, Yang ZY
    EFEMP2 increases the invasion ability of cervical cancer cells by promoting EMT via the Raf/MEK/ERK signaling pathway.
    Neoplasma. 2022 Aug 24. pii: 220117N74. doi: 10.4149/neo_2022_220117.
    PubMed         Abstract available


    Nucl Med Commun

  54. LIU Y, Hua J, Liu L, Zhang W, et al
    The value of the SUV ratio between lymph node and bone marrow in predicting pelvic lymphatic metastasis of patients with locally advanced cervical cancer: an integrated PET/CT study.
    Nucl Med Commun. 2022 Aug 25. pii: 00006231-990000000-00057.
    PubMed         Abstract available


    Oncogene

  55. DU QY, Huo FC, Du WQ, Sun XL, et al
    METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA.
    Oncogene. 2022 Aug 20. pii: 10.1038/s41388-022-02435.
    PubMed         Abstract available


    Pak J Med Sci

  56. LI H, Li L, Sun J, Dong S, et al
    Value of TCT combined with serum CA153 and CA50 in early diagnosis of cervical cancer and precancerous lesions.
    Pak J Med Sci. 2022;38:1471-1476.
    PubMed         Abstract available


    Pak J Pharm Sci

  57. ALTUN A, Sahin Inan ZD, Yulak F
    Death receptor-dependent apoptosis and cell cycle delay induced by bioymifi in human cervical cancer cells.
    Pak J Pharm Sci. 2022;35:1031-1036.
    PubMed         Abstract available


    Pathol Oncol Res

  58. JIANG L, Li D, Wang C, Liao J, et al
    Decreased Expression of Karyopherin-alpha 1 is Related to the Malignant Degree of Cervical Cancer and is Critical for the Proliferation of Hela Cells.
    Pathol Oncol Res. 2022;28:1610518.
    PubMed         Abstract available


    Prev Med

  59. MAKADZANGE EE, Peeters A, Joore MA, Kimman ML, et al
    The effectiveness of health education interventions on cervical cancer prevention in Africa: A systematic review.
    Prev Med. 2022 Aug 22:107219. doi: 10.1016/j.ypmed.2022.107219.
    PubMed         Abstract available


    Psychooncology

  60. RAJKUMAR D, Veeraiah S, Sudhakar R, Ganeshrajah S, et al
    Perceived psychosexual dimensions of cervical cancer survivors in India-An exploratory study.
    Psychooncology. 2022 Aug 20. doi: 10.1002/pon.6021.
    PubMed         Abstract available


    Reprod Sci

  61. WANG J, Chen X, Zheng L, Ding C, et al
    Circ_0042986 Presence Restrains Cervical Cancer Development via Upregulating PEG3 by Directly Targeting miR-582-3p.
    Reprod Sci. 2022 Aug 26. pii: 10.1007/s43032-022-01053.
    PubMed         Abstract available


    Rev Panam Salud Publica

  62. CERQUEIRA RS, Dos Santos HLPC, Prado NMBL, Bittencourt RG, et al
    [Control of cervical cancer in the primary care setting in South American countries: systematic reviewControl del cancer cervicouterino en los servicios de atencion primaria de salud en los paises de America del Sur: revision sistematica].
    Rev Panam Salud Publica. 2022;46:e107.
    PubMed         Abstract available


    Scand J Public Health

  63. DE PREZ V, Jolidon V, Cullati S, Burton-Jeangros C, et al
    Cervical cancer (over-)screening in Europe: Balancing organised and opportunistic programmes.
    Scand J Public Health. 2022 Aug 25:14034948221118215.
    PubMed         Abstract available


    Scanning

  64. LU A, Lu G
    Application of MRI and CT Images in Surgical Treatment of Early Cervical Cancer.
    Scanning. 2022;2022:1592449.
    PubMed         Abstract available


    Sci Rep

  65. FUJITA M, Nagashima K, Shimazu M, Suzuki M, et al
    Implementation of a self-sampling HPV test for non-responders to cervical cancer screening in Japan: secondary analysis of the ACCESS trial.
    Sci Rep. 2022;12:14531.
    PubMed         Abstract available

  66. AARTHY M, Muthuramalingam P, Ramesh M, Singh SK, et al
    Unraveling the multi-targeted curative potential of bioactive molecules against cervical cancer through integrated omics and systems pharmacology approach.
    Sci Rep. 2022;12:14245.
    PubMed         Abstract available


    Sovrem Tekhnologii Med

  67. KURMYSHKINA OV, Bogdanova AA, Kovchur PI, Fetyukov AI, et al
    RNA Sequencing and Cell Models of Virus-Associated Cancer (Review).
    Sovrem Tekhnologii Med. 2022;14:64-80.
    PubMed         Abstract available


    Vaccines (Basel)

  68. DI GIUSEPPE G, Folcarelli L, Lanzano R, Napolitano F, et al
    HPV Vaccination and Cervical Cancer Screening: Assessing Awareness, Attitudes, and Adherence in Detained Women.
    Vaccines (Basel). 2022;10.
    PubMed         Abstract available


    Virusdisease

  69. OJHA PS, Maste MM, Tubachi S, Patil VS, et al
    Human papillomavirus and cervical cancer: an insight highlighting pathogenesis and targeting strategies.
    Virusdisease. 2022;33:132-154.
    PubMed         Abstract available


    Viruses

  70. RAMON AC, Basukala O, Massimi P, Thomas M, et al
    CIGB-300 Peptide Targets the CK2 Phospho-Acceptor Domain on Human Papillomavirus E7 and Disrupts the Retinoblastoma (RB) Complex in Cervical Cancer Cells.
    Viruses. 2022;14.
    PubMed         Abstract available


    World J Surg Oncol

  71. HUANG Y, Chen L, Cai J, Yang L, et al
    Neoadjuvant chemotherapy followed by radical surgery reduces radiation therapy in patients with stage IB2 to IIA2 cervical cancer.
    World J Surg Oncol. 2022;20:264.
    PubMed         Abstract available


    Zhonghua Fu Chan Ke Za Zhi

  72. ZHAO YQ, Qiao YL, Lang YH
    [Challenges and opportunities to accelerate cervical cancer elimination in China].
    Zhonghua Fu Chan Ke Za Zhi. 2022;57:581-586.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: